XFOR
X4 Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.77 / 10
Netural
Analyst sentiment is overwhelmingly bullish, with a single Strong Buy recommendation, yet its historical win rate is zero and average return negative. Fund‑flow score is strong at 7.54, showing net inflows, though trends across all investor sizes are currently negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Michael Werner SchmidtStrong Buy
Date2026-03-09
InstitutionGuggenheim
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for XFOR?
- XFOR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.77/10 (Netural).
